Form 4 for PCVX Vaxcyte, Inc.

Accepted 2024-06-05 00:00:00 ET · period of report 2024-06-03 · accession 0001415889-24-015587 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2024-06-05	2024-06-03	PCVX	Wassil Jim	COO	S - Sale	$71.99	-3,000	213.5K	-1%	-$216.0K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-06-03	S	D	906	$72.32	213,964	D	—	—	(F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $72.01 to $72.67. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
2	Common	Common Stock	2024-06-03	S	D	1,634	$71.38	214,869	D	—	—	(F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $70.98 to $71.94. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. (F3) Includes 1,041 shares acquired under the Issuer's Employee Stock Purchase Plan on May 17, 2024.
3	Common	Common Stock	2024-06-03	S	D	460	$73.48	213,503	D	—	—	(F5) The price reported is a weighted-average price. The shares were sold at prices ranging from $73.41 to $73.54. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.